INSIGHTS ON QUALITY CONTROL
-
Aggregate Analysis Of Tirzepatide
A new size exclusion method effectively analyzes Tirzepatide aggregates, demonstrating robust separation and reproducibility with minimal need for organic solvents or acidic modifiers.
-
Integration Of Container Closure Integrity In Contract Manufacturing
Maintaining drug product sterility and compliance demands rigorous Container Closure Integrity (CCI) within contract manufacturing. Learn how to fortify your processes.
-
Software Simplifies 21 CFR Part 11 and Annex 11 Compliance
21 CFR Part 11 and Annex 11 regulate electronic records and signatures in biomanufacturing, ensuring data integrity, security, and compliance while enabling efficient processes and regulatory alignment.
-
Building Control Strategies: It's Time To Go Digital
Digital control strategies in pharma enhance product quality, regulatory compliance, and efficiency by leveraging real-time monitoring, automated documentation, and Quality by Design (QbD) frameworks.
-
Experience The Future Of Bioseparations4/16/2024
Learn about an HPLC System designed to improve outcomes in QC labs with ease of use and simplicity at its core.
-
Enhance Peptide Innovation With A High-Quality Supply Of Building Blocks1/29/2025
To leverage the benefits of peptide therapeutics, identify an experienced chemical material manufacturer that can produce unique peptide building blocks with quality, efficiency, and continuous compliance.
-
A CDMO's Take On Psychedelic Formulation1/26/2026
Psychedelics show therapeutic promise, but face major formulation and regulatory hurdles. Advances in delivery and neuroscience may unlock new mental‑health treatments.
-
Delivering Value Across Sites With Unified Quality Operations1/21/2026
Standardizing quality processes across 14 sites has enabled faster lead times. Discover how a unified platform reduces complexity, improves compliance, and delivers greater value for customers.
-
Activate Advanced Contamination Control Technology To Safeguard Your Cell Therapy2/6/2026
The most common contamination risks in cell therapy manufacturing are open processes that leverage different products, inflexible instruments, labor intensive workflows, lack of in-line monitoring, and zero failure tolerance.
QUALITY CONTROL SOLUTIONS
-
Pharmaceutical companies face cost, complexity, and speed pressures. Inspection solutions support quality and compliance with fill detection, weighing, foreign body detection, and label verification.
-
Understand how to confidently meet GxP compliance in the life sciences. Explore a framework encompassing people, processes, products, and services for regulatory adherence and data integrity.
-
Mikart’s small-scale non-GMP lab accelerates development by enabling rapid testing and iteration at a lower cost.
-
The Milliflex® Rapid System 2.0 brings together membrane filtration and ATP bioluminescence to detect, image and quantify microcolonies of bacteria, molds and yeasts up to 4 times faster than compendial bioburden or sterility testing methods.
-
The pharmaceutical industry continues to bring breakthroughs in the field of new vaccines and drug delivery systems amidst the increased scrutiny of the regulators. The packaging acts as the primary sterile barrier in drug delivery systems that safeguard the drug product through its life cycle. The efficiency of the primary sterile barrier and the functional components are of utmost importance to patient safety.